financetom
Business
financetom
/
Business
/
Titanium dioxide maker Tronox's Q3 revenue down 13%, misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Titanium dioxide maker Tronox's Q3 revenue down 13%, misses estimates
Nov 5, 2025 3:02 PM

Overview

* Tronox Q3 2025 revenue of $699 mln missed analyst expectations, down 13% yr/yr

* Adjusted EPS for Q3 2025 missed consensus, reflecting ongoing market challenges

* Adjusted EBITDA for Q3 2025 missed analyst expectations, impacted by lower sales volumes

Outlook

* Company expects Q4 2025 revenue and Adjusted EBITDA to be flat compared to Q3 2025

* Tronox ( TROX ) anticipates TiO(2) volume growth of 3-5% and zircon volume growth of 15-20%

* Company expects positive free cash flow in Q4 2025 and 2026

Result Drivers

* WEAKER DEMAND - CEO John Romano cites weaker than expected demand and aggressive inventory liquidation by competitors as impacting Q3 results

* COST IMPROVEMENT - Tronox's ( TROX ) cost improvement program ahead of schedule, aiming for $60 mln savings by end of 2025

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $699 mln $768.80

Revenue mln (8

Analysts

)

Q3 Miss -$0.46 -$0.14

Adjusted (9

EPS Analysts

)

Q3 Net -$99 mln

Income

Q3 Miss $74 mln $93.40

Adjusted mln (7

EBITDA Analysts

)

Q3 10.60%

Adjusted

EBITDA

Margin

Q3 -$43 mln

Income

From

Operatio

ns

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 3 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the specialty chemicals peer group is "buy."

* Wall Street's median 12-month price target for Tronox Holdings PLC ( TROX ) is $4.25, about 24.9% above its November 4 closing price of $3.19

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Stellantis to Buy Carbon Credits From Tesla to Meet Europe Emissions Rules
Market Chatter: Stellantis to Buy Carbon Credits From Tesla to Meet Europe Emissions Rules
Mar 31, 2025
07:15 AM EDT, 03/31/2025 (MT Newswires) -- Stellantis ( STLA ) will buy carbon credits from a pool led by Tesla (TSLA) to meet the European Union's CO2 reduction requirements, the group's head of European operations Jean-Philippe Imparato said at an event on Saturday, Reuters reported. Carmakers agreed to pool their emissions and avoid EU fines by having firms with...
Yum Brands CEO Gibbs to retire in 2026
Yum Brands CEO Gibbs to retire in 2026
Mar 31, 2025
March 31 (Reuters) - KFC ( YUM ) parent Yum Brands ( YUM ) said on Monday CEO David Gibbs has informed the board of his intention to retire from the company next year. Gibbs, who joined the company in 1989 as an executive for Taco Bell, took on the role of Yum's chief executive officer in January 2020. The...
Astrazeneca Receives Approval Recommendation for Calquence Combination Therapy in Europe
Astrazeneca Receives Approval Recommendation for Calquence Combination Therapy in Europe
Mar 31, 2025
07:17 AM EDT, 03/31/2025 (MT Newswires) -- Astrazeneca ( AZN ) said Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval for Calquence, in combination with bendamustine and rituximab, as a treatment for adult patients with previously untreated mantle cell lymphoma. The company said the recommendation was based on the results of a...
Germany's DHL to acquire U.S. pharma logistics firm Cryopdp, source says
Germany's DHL to acquire U.S. pharma logistics firm Cryopdp, source says
Mar 31, 2025
DUSSELDORF, Germany, March 31 (Reuters) - Germany's DHL has agreed to acquire U.S. pharmaceutical logistics firm Cryopdp for a three-digit million-euro sum, a source familiar with the matter said on Monday. (Reporting by Matthias Inverardi, Writing by Rachel More, Editing by Thomas Seythal) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved